@techcrunch.com 4 years ago
With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests
@xconomy.com 5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M